Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Abengoa S.A. (OTC: AGOAF).

Full DD Report for AGOAF

You must become a subscriber to view this report.


Recent News from (OTC: AGOAF)

ABGOY - Books closed today, March 27, 2017
ABGOY - Books closed today, March 27, 2017
Source: OTC Markets
Date: March, 27 2017 00:00
Books will close today January 20th, 2016.
Books will close today January 20th, 2016.
Source: OTC Markets
Date: January, 20 2016 00:00

 


About Abengoa S.A. (OTC: AGOAF)

Logo for Abengoa S.A. (OTC: AGOAF)

Abengoa MCE: ABG is an international company that applies innovative technology solutions for sustainability in the energy and environment sectors, generating energy from the sun, producing biofuels, desalinating sea water and recycling industrial waste.

 

Contact Information

 

 

Current Management

  • Miguel Angel JimenezVelasco Maz / Secretary
  • Barbara Zubiria / Director, Inv. Rel.
  • Felipe Benjumea Llorente / Executive Chairman
  • Jose A. Terceiro / Executive Vice Chairman

Current Share Structure

     


    Recent Filings from (OTC: AGOAF)

    Post-effective amendment to a previously filed F-6
    Filing Type: F-6 POSFiling Source: edgar
    Filing Date: September, 29 2017
    Amendment to the SC 13G filing
    Filing Type: SC 13G/AFiling Source: edgar
    Filing Date: February, 14 2017
    Filed by Foreign issuer
    Filing Type: 15F-12BFiling Source: edgar
    Filing Date: April, 29 2016
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: April, 26 2016
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: April, 22 2016
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: April, 19 2016
    Notification of the removal from listing and registration of matured, redeemed or retired Securities
    Filing Type: 25Filing Source: edgar
    Filing Date: April, 18 2016
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: April, 14 2016
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: April, 06 2016
    Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
    Filing Type: 6-KFiling Source: edgar
    Filing Date: April, 06 2016

     

     


    Daily Technical Chart for (OTC: AGOAF)

    Daily Technical Chart for (OTC: AGOAF)


    Stay tuned for daily updates and more on (OTC: AGOAF)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (OTC: AGOAF)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    OTC Report
    @OTCReporter

     

     


    Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AGOAF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of AGOAF and does not buy, sell, or trade any shares of AGOAF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/